| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 128 |
| 1 | SERTRALINE | 77 |
| 2 | ESCITALOPRAM | 46 |
| 3 | SILDENAFIL CITRATE | 44 |
| 4 | ESCITALOPRAM OXALATE | 38 |
| 5 | ESCITSLOPRAM | 36 |
| 6 | CITALOPRAM | 35 |
| 7 | CITALOPRAM HYDROBROMIDE | 34 |
| 8 | ATOMOXETINE HYDROCHLORIDE | 28 |
| 9 | BUPROPION HYDROCHLORIDE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-TYROSINE | 1 | 0.0074 |
| 1 | GABA (GAMMA-AMINOBUTYRIC ACID) | 1 | 0.0047 |
| 2 | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HCL | 1 | 0.0042 |
| 3 | BREMELANOTIDE | 3 | 0.0026 |
| 4 | CEFADROXIL | 5 | 0.0025 |
| 5 | FINASTERIDE | 128 | 0.0021 |
| 6 | ILOPERIDONE | 3 | 0.0020 |
| 7 | ATOMOXETINE HYDROCHLORIDE | 28 | 0.0012 |
| 8 | OMAVELOXOLONE | 2 | 0.0011 |
| 9 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 131 |
| 1 | Atypical Antipsychotic [EPC] | 43 |
| 2 | Benzodiazepine [EPC] | 35 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 30 |
| 5 | Serotonin Reuptake Inhibitor [EPC] | 29 |
| 6 | Progestin [EPC] | 26 |
| 7 | Progestin-containing Intrauterine System [EPC] | 23 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | Estrogen [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 131 | 0.0013 |
| 1 | Estrogen Agonist/Antagonist [EPC] | 2 | 0.0008 |
| 2 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 3 | Serotonin Reuptake Inhibitor [EPC] | 29 | 0.0003 |
| 4 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 30 | 0.0002 |
| 6 | Androgen [EPC] | 5 | 0.0002 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |